The rationale, design, and progress of two novel maintenance treatment studies in pediatric bipolarity.
DISCUSSION: Since the blind has not been broken on either of these clinical trials, conclusions about the maintenance effectiveness of either VPA or Li+ in youths with bipolar disorder type 1 or 2 cannot be made yet. Similarly, it is unclear whether VPA is superior to placebo in genetically high-risk youths with cyclotaxia. The final results of these trials should provide valuable information about the treatment of juvenile bipolar disorders.
PMID: 26975273 [PubMed]
Source: Acta Neuropsychiatrica - Category: Psychiatry Tags: Acta Neuropsychiatr Source Type: research
More News: Bipolar | Children | Clinical Trials | Divalproex Sodium | Eyes | Genetics | Hospital Management | Lithium | Lithium Carbonate | Mania | Neurology | Orthopaedics | Pediatrics | Psychiatry | Study